AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Discover how wealth growth through investments and savings can lead to financial independence. Make smart choices for your financial future today.
28,655 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
As AI surges, regulators move faster than hype. Markets put odds of model access curbs at about 27.5% for 2026, reviv...
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Bitcoin surged to a three-month high, topping the $82,000 mark amid fresh geopolitical chatter and improving market s...
NVIDIA CEO Jensen Huang's praise for Marvell sparks a broad rally in optical suppliers, lifting Lumentum and Coherent...
Rocket Lab CEO Peter Beck argues that only two firms have achieved scalable space launches, a stance that investors a...
A decade after The DAO hack drained millions of ETH, the crypto security landscape has matured into a cooperative, mu...
AVUV has climbed this year, but rate expectations and bank exposure keep its outlook uncertain. Here’s what AVUV inve...
CoreWeave’s billion funding haul underscores a shifting liquidity landscape, with AI infrastructure drawing tens of b...
Analysts highlight three candidates with durable networks and real use cases, exploring chances for outsized gains by...
Oil prices cooled slightly on June 5, 2026, as Brent traded near $97.44 a barrel at 9 a.m. ET, signaling a cautious p...
DeXe shows resilience as on-chain activity climbs and wallet growth accelerates amid a broader market downturn. Analy...